Table 3.
VAS and OKS scores in both groups during the follow-up.
| Mesotherapy group | Oral therapy group | p value (within groups) | p value (between groups) | |
|---|---|---|---|---|
| VASa, mean, SDb | 0.001 | |||
| Baseline | 8.25 ± 1.99 | 7.45 ± 1.68 | 0.07 | |
| 2nd week | 5.25 ± 1.99 | 5.22 ± 2.27 | 0.95 | |
| 4th week | 3.51 ± 2.17 | 4.48 ± 2.06 | 0.07 | |
| 8th week | 3.12 ± 2.09 | 3.38 ± 2.02 | 0.62 | |
|
| ||||
| OKSc, mean ± SD | Mesotherapy group: 0.001 Oral therapy group: 0.04 |
|||
| Baseline | 22.93 ± 7.57 | 21.13 ± 4.54 | 0.11 | |
| 2nd week | 31.60 ± 8.28 | 25.33 ± 5.93 | 0.03 | |
| 4th week | 38.41 ± 9.12 | 27.25 ± 6.99 | 0.01 | |
| 8th week | 39.05 ± 15.32 | 30.22 ± 8.10 | 0.01 | |
aVAS, Visual Analogue Scale; bSD, standard deviation; cOKS, Oxford Knee Scale.